41/168US=30 / Cirurgia
Gawad KA, Busch C, Broering DC, Yekebas EF. Preoperative evaluation of the operative risk profile. In: Izbicki JR, Broering DC, Yekebas EF, Kutup A, Chernousov AF, Gallinger YI, Bogopolski PM, Soehendra N. Surgery of the esophagus: textbook and atlas of surgical practice. Philadelphia: Springer, 2009. p. 39-41. ISBN 978-3-7985-1309-9.

CANCER DE ESOFAGO; RISCO OPERACIONAL; AVALIACAO PRE-OPERATORIA


42/168US=47 / Urologia
Hogle WP. Prostate cancer screening, risk, prevention, and prognosis. In: ___. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 19-34. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA. TRIAGEM; CANCER DE PROSTATA. FATORES DE RISCO; CANCER DE PROSTATA. PREVENCAO; CANCER DE PROSTATA. PROGNOSTICO


43/168US=51 / Biol/Mol
Baty BJ. Risk communication and decision-making. In: Uhlmann WR, Schuette JL, Yashar BM. A guide to genetic counseling. 2ª ed. New Jersey: Wiley, 2009. p. 207-50. ISBN 978-0-470-17965-9.

ACONSELHAMENTO GENETICO; COMUNICACAO; TOMADA DE DECISAO; COMUNICACAO DE RISCO


44/168US=87 / Biol/Mol
Earl J, Greenhalf W. Single-nucleotide polymorphism (SNP) analysis to associate cancer risk. In: Grützmann R, Pilarsky C. Cancer gene profiling: methods and protocols. New York: Humana Press, 2009. p. 171-96. (Methods in Molecular Biology, 576) ISBN 978-1-934115-76-3.

POLIMORFISMOS DE NUCLEOTIDEO UNICO (SNP); CANCER NA FAMILIA; MATRIZES; ASSOCIACAO; LIGACAO


45/168US=96 / Biol/Mol
Parl FF, Dawling S, Roodi N, Crooke PS. Estrogen metabolism and breast cancer: a risk model. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 68-75. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; METABOLISMO; CANCER DE MAMA; RISCO; GENOTIPO; MODELO


46/168US=96 / Biol/Mol
Balistreri CR, Carruba G, Calabrò M, Campisi I, Di Carlo D, Lio D, Colonna-Romano G, Candore G, Caruso C. CCR5 proinflammatory allele in prostate cancer risk. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 289-92. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE PROSTATA; INFLAMACAO; CCR5&*916;32 EXCLUSAO


47/168US=23-D / Câncer
Lu SN, Wang JH, Kee KM, Tseng PL. Screening with ultrasonography of patients at high-risk for hepatocellular carcinoma: thrombocytopenia as a valid surrogate of cirrhosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 137-44. ISBN 978-1-4020-9803-1.

EPIDEMIOLOGIA DO CARCINOMA HEPATOCELULAR; EPIDEMIOLOGIA DA CIRROSE HEPATICA; BENEFICIO DO RASTREIO HCC; CIRROSE HEPATICA. TESTES DE SUBSTITUICAO; FRIBOSIS. ESTES DE SUBSTITUICAO; RASTREIO HCC ECOGRAFICA. ADULTO TROMBOCITOPENICA


48/168US=16-A / Estatística
Brüske-Hohlfeld I. Environmental and occupational risk factor for lung cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 3-23. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3.

CANCER DE PULMAO; FUMACA DE CIGARRO; AMIANTO; RADONIO EM RESIDENCIAS; ARSENICO NA AGUA POTAVEL; BERILIO; BIS-CLOROMETIL ETER; CADMIO; CICKEL; HIDROCARBONETOS AROMATICOS POLICICLICOS


49/168US=16-A / Estatística
Fair AM, Montgomery K. Energy balance, physical activity, and cancer risk. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 57-88. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3.

BALANCO ENERGETICO; ATIVIDADE FISICA; RISCO DE CANCER; ADENOCARCINOMA; BALANCO DE ENERGIA; INSULIN-LIKE GROWTH FACTOR-1; NUTRICAO; OBESIDADE; ATIVIDADE FISICA


50/168US=16-A / Estatística
Boyd NF, Martin LJ, Rommens JM, Parterson AD, Minkin S, Yaffe MJ, Stone J, Hopper JL. Mammographic density: a heritable risk factor for breast cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 343-60. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3.

DENSIDADE MAMOGRAFICA. FATOR DE RISCO PARA CANCER DE MAMA HEREDITARIO; CANCER DE MAMA; FATORES HEREDITARIOS; DENSIDADE MAMOGRAFICA


51/168US=16-A / Estatística
Lin OS. Acquired risk factors for colorectal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 361-72. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3.

CANCER COLORRETAL. FATORES DE RISCO; CANCER COLORRETAL; ADENOMA; FATORES DE RISCO; FIBRA; INFLAMATORIO; DOENCA INTESTINAL; VIGILANCIA


52/168US=10 / Urologia
Klotz L, Volpe A. Role of surgery in the management of high-risk localized prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 143-9. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; CIRURGIA; GESTAO DE ALTO RISCO; TRATAMENTO


53/168US=10 / Urologia
Horwitz EM, Feigenberg SJ, Pollack A. Initial management of high risk early stage prostate cancer: radiation. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 205-11. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; RADIACAO; TECNICAS DE TRATAMENTO RADIOATIVO


54/168US=10 / Gastro
Mocchegiani F, Ghiselli R, Cappelletti M, Saba V. Epidemiology, risk factors, and prevention of pancreatic cancer. In: Siquini W, editor. Surgical treatment of pancreatic diseases. New York: Springer, 2008. p. 177-87. ISBN 978-88-470-0855-7.

CANCER DE PANCREAS. FATORES DE RISCO; CANCER DE PANCREAS. PREVENCAO; CANCER DE PANCREAS. TRATAMENTO; CANCER DE PANCREAS. DOENCA HEREDITARIA


55/168US=14 / Câncer
Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A. HER-2/neu I1e655val polymorphism and the risk of breast cancer. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 84-94. ISBN 978-1-57331-700-9.

CANCER DE MAMA; HER-2/NEU; POLIMORFISMO; RISCOS


56/168Câncer
Pellizzon ACA, Boccaletti K, Belletti F. Impact and evaluation of the use of tri-dimensional over bi-dimensional plan for the breast and axillary lymph node irradiation with tangential fields for conservative breast cancer treatment. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 92-6, 2011. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.92-6.pdf

RADIOTERAPIA; NEOPLASIAS DA MAMA; IMAGEM; LINFONODO AXILIAR; TRIDIMENCIONAL


57/168Câncer
Loyola EAT, França BHS, Moysés SJ, Moysés ST, Bisinelli JC. Oral cancer, smoking and public health policies in Brazil: a brief review. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 102-6, 2011. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.102-6.pdf

PROMOCAO DE SAUDE; NEOPLASIAS DE BOCA; CANCER ORAL; SAUDE PUBLICA; FATOR DE RISCO; CIGARRO


58/168US=21 / Odontologia
Holmes SM, Udey DK. Risk management in oral and maxillofacial surgery. In: Brandt MT, Haug RH. Oral and maxillofacial surgery clinics: practice management. Philadelphia: Elsevier Saunders, 2008. p. 119-26. (20) ISBN 978-1-55009-345-2.

GESTAO DE RISCO EM CIRURGIA ORAL E MAXILOFACIAL


59/168US=23 / Câncer
Bult P, Hoogerbrugge N. Familial breast cancer: detection of prevalent high-risk epithelial lesions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 61-71. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA FAMILIAR; CARCINOMA LOBULAR IN SITU; HIPERPLASIA LOBULAR ATIPICA; CARCINOMA DUCTAL IN SITU; HIPERPLASIA DUCTAL ATIPICA


60/168US=23 / Câncer
Baltzell K, Mills D, Ljung BM, Love S, Wrensch M. Breast cancer risk in women with abnormal cytology in nipple aspirate fluid. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 203-16. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOLOGIA ANORMAL; FLUIDO ASPIRADO; AVALIACAO DE RISCO; DUCTO MAMARIO. ANATOMIA; FLUIDO DO ASPIRADO DE MAMILO; NAF


Primeira | Anterior | Próxima | Última